최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Food science and biotechnology, v.27 no.3, 2018년, pp.853 - 857
Kim, Ji Yeon (Department of Food Science and Technology, Seoul National University of Science and Technology) , Park, Yeo Jin (Department of Nutritional Science and Food Management, Ewha Womans University) , Lee, Hyo Jin (Department of Nutritional Science and Food Management, Ewha Womans University) , Park, Min Young (Department of Nutritional Science and Food Management, Ewha Womans University) , Kwon, Oran (Department of Nutritional Science and Food Management, Ewha Womans University)
Lactobacillus gasseri BNR17 is a strain isolated from human breast milk. The objective of this randomized, double-blind, placebo-controlled, and preliminary dose-finding trial was to find the effective dose and evaluate the effect of Lb. gasseri BNR17 on irritable bowel syndrome (IBS) symptoms. A to...
Wang JR, Xing ZQ, Tang W, Zheng YN, Wang YP. Isolation, identi?cation, and potential probiotic characterization of one Lactococcus from Ke?r grain. Food Sci Biotechnol 24: 1775-1780 (2015)
Yao X, Yang YS, Cui LH, Zhao KB, Zhang ZH, Peng LH, Guo X, Sun G, Shang J, Wang WF, Feng J, Huang Q. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study. J Gastroenterol Hepatol 27: 760-5 (2012)
Jung HK, Kim YH, Park JY, Jang BH, Park SY, Nam MH, Choi MG. Estimating the burden of irritable bowel syndrome: analysis of a nationwide korean database. J Neurogastroenterol Motil 20: 242-52 (2014)
American College of Gastroenterology Task Force on Irritable Bowel S, Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 104 Suppl 1: S1-35 (2009)
Brandt LJ, Bjorkman D, Fennerty MB, Locke GR, Olden K, Peterson W, Quigley E, Schoenfeld P, Schuster M, Talley N. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 97: S7-26 (2002)
Whelan K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care 14: 581-7 (2011)
Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol 104: 1033-49; quiz 1050 (2009)
Yun SI, Park HO, Kang JH. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol 107: 1681-6 (2009)
Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, Kim JY. Effect of Lactobacillus gasseri BNR17 on Overweight and Obese Adults: A Randomized, Double-Blind Clinical Trial. Korean J Fam Med 34: 80-9 (2013)
Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One 8: e54617 (2013)
Quan C, Talley NJ, Cross S, Jones M, Hammer J, Giles N, Horowitz M. Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther 17: 1179-87 (2003)
Kajander K, Hatakka K, Poussa T, Farkkila M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 22: 387-94 (2005)
Zimmerman J. Extraintestinal symptoms in irritable bowel syndrome and in?ammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms. Dig Dis Sci 48: 743-9 (2003)
Takahashi H, Fujita T, Suzuki Y, Benno Y. Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol Immunol 50: 867-70 (2006)
Ducrotte P, Sawant P, Jayanthi V. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J Gastroentero 18: 4012-4018 (2012)
Haller D, Antoine JM, Bengmark S, Enck P, Rijkers GT, Lenoir-Wijnkoop I. Guidance for substantiating the evidence for bene?cial effects of probiotics: probiotics in chronic in?ammatory bowel disease and the functional disorder irritable bowel syndrome. J Nutr 140: 690S-7S (2010)
Jankovic I, Sybesma W, Phothirath P, Ananta E, Mercenier A. Application of probiotics in food products-challenges and new approaches. Curr Opin Biotech 21: 175-181 (2010)
Fujiwara S, Seto Y, Kimura A, Hashiba H. Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its in?uence on intestinal micro?ora and metabolism. J Appl Microbiol 90: 343-52 (2001)
Olivares M, Diaz-Ropero MA, Gomez N, Lara-Villoslada F, Sierra S, Maldonado JA, Martin R, Lopez-Huertas E, Rodriguez JM, Xaus J. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. Int J Food Microbiol 107: 104-11 (2006)
Takagi A, Yanagi H, Ozawa H, Uemura N, Nakajima S, Inoue K, Kawai T, Ohtsu T, Koga Y. Effects of Lactobacillus gasseri OLL2716 on Helicobacter pylori-Associated Dyspepsia: A Multicenter Randomized Double-Blind Controlled Trial. Gastroenterol Res Pract 2016: 7490452 (2016)
Alok A, Singh ID, Singh S, Kishore M, Jha PC, Iqubal MA. Probiotics: A New Era of Biotherapy. Adv Biomed Res 6: 31 (2017)
Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg RM, Moller K, Svendsen KD, Jakobsen M, Pedersen BK. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic in?ammatory response in human subjects. Br J Nutr 104: 1831-8 (2010)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.